Scannexus and AMRA join forcesoctober 2, 2017
- Scannexus, world-leading Ultra High-Field MRI facility based in Maastricht Netherlands, incorporates AMRA into service offering for researchers
- AMRA partners with Scannexus, thus strengthening academic relationships and clinical research opportunities in Europe
- Precise measurement of fat and muscle tissue highly valuable to researchers focusing upon metabolic disease, such as obesity and diabetes
AMRA, the international leader in body composition analysis, today announced a partnership with Scannexus, a world-leading Ultra High-Field MRI scanner facility located at the Brightlands Maastricht Health Campus. The partnership was confirmed with official signatures of the collaboration agreement and a full-day AMRA introduction seminar to the Brightlands Maastricht Health Community.
Together, Scannexus and AMRA offer something new to the research community: the ability to translate a 6-minute whole body MRI scan into precise, 3D-volumetric fat and muscle measurements using scanners at Scannexus. This is good news for researchers in the Netherlands, including Maastricht and surrounding clinical research centers, as AMRA® Profiler Researcher makes it possible to understand metabolic diseases, such as obesity and diabetes.
Ultra-High-MR imaging provides new levels of insights into human anatomy and function, opening up a range of possibilities with implications for medical diagnosis and treatment. Using AMRA’s tool, AMRA® Profiler Research, researchers can now quantitatively measure fat and muscle tissue content using the same MRI scanners. Scannexus is the perfect partner for this, as the company has three ultra-high MRI scanners used intensively for research.
The CEO of AMRA (Advanced MR Analytics AB) Tommy Johansson came to Maastricht especially for the signing.
“The collaboration with Scannexus would bring AMRA, a research-based company, closer to the center of excellence in Human Biology, NUTRIM and other clinics at Maastricht UMC+ and in the Netherlands. This would add to the understanding of body composition and risk profiling of metabolic diseases.”
Scannexus’ CEO, Albert Scherpbier, responded that the bundling of strengths will allow them to open up a new market.
“The partnership with AMRA makes it possible to get scan results produced at Scannexus and Maastricht UMC+ to researchers much faster. Researchers now have one point of contact for assistance with their research.”
AMRA is an international digital health company and the first in the world to transform images from a 6-minute whole body MRI scan into precise, 3D-volumetric fat and muscle measurements. AMRA’s cloud-based analysis service – AMRA® Profiler Research – offers automated insights that have far-reaching implications for the pharma industry, academic R&D and, soon, clinical practice.
Headquartered in Sweden, AMRA was founded in 2010 as a spin-off of the Center for Medical Image Science and Visualization (CMIV), the Department of Biomedical Engineering (IMT) and the Department of Medicine and Health (IMH) at Linköping University, Sweden. For more information, visit: www.amra.se